Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8H-purin-8-one Inhibitors of DNA-PK. - Goldberg FW; Ting AKT; Beattie D; Lamont GM; Fallan C; Finlay MRV; Williamson B; Schimpl M; Harmer AR; Adeyemi OB; Nordell P; Cronin AS; et al. (ACS medicinal chemistry letters, 2022)